共 22 条
- [1] Bartkowiak D., Schumann J., Otto F.J., Lippold A., Drepper H., DNA flow cytometry in the prognosis of primary malignant melanoma, Oncology, 48, pp. 39-43, (1991)
- [2] Bines S.D., Vonroenn J.H., Kheir S.M., Coon J.S., Flow cytometry in melanoma, Nathanson L, pp. 155-169, (1988)
- [3] Kheir S.M., Bines S.D., Vonroenn J.H., Soong S.J., Urist M.M., Coon J.S., Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma, Ann Surg, 207, pp. 455-461, (1988)
- [4] S0ndergaard K., Larsen J.K., Moller U., Christensen I.J., Hou-Jensen K., DNA ploidy-characteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course, Virchows Arch (Cell Pathol), 42, pp. 43-52, (1983)
- [5] Muhonen T., Pyrhonen S., Laasonen A., Asko-Seljavaara S., Franssila K., DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma, Br J Cancer, 64, pp. 749-752, (1991)
- [6] Bartkowiak D., Otto F., Schumann J., Lippold A., Drepper H., Sequential D., Flow cytometry in metastatic malignant melanoma, Oncology, 48, pp. 154-157, (1991)
- [7] Hansson J., Tribukait B., Lewensohn R., Ringborg U., Flow Cytofluorometric DNA analyses of metastases of human malignant melanomas, Anal Quant Cytol, 4, pp. 99-104, (1982)
- [8] Zaloudik J., Moore M., Ghosh A.K., Mechl Z., Rejthar A., DNA content and MHC class II antigen expression in malignant melanoma: Clinical course, J Clin Pathol, 41, pp. 1078-1084, (1988)
- [9] Karlsson M., Boeryd B., Carstensen J., Et al., DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease, Br J Cancer, 67, pp. 134-138, (1993)
- [10] Schutte B., Reynders M., Bosman F.T., Blijham G.H., Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue, Cytometry, 6, pp. 26-30, (1985)